A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant Women

Clinical trial NCT07596199 · RECRUITING

Trial details

NCT number: NCT07596199
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria-Tetanus-acellular Pertussis Vaccines

Start date: 2026-06-29
Primary completion: 2026-12-11
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.